Harpoon Therapeutics raises $45 mln from Arix, New Leaf, others
Harpoon Therapeutics said it raised $45 million of Series B financing in a deal co-led by Arix Bioscience and New Leaf Venture Partners and joined by new investor Taiho Ventures and existing investor MPM Capital.
25 May 2017•1 min read
